hospitalization required Maintenance of Remission: Immunomodulators (azathioprine, 6-MP, methotrexate) for steroid-dependent or frequently-relapsing disease Biologic monotherapy or combination therapy (biologic + immunomodulator) for moderate-to-severe disease Step-up or top-down approach based on disease severity, patient risk factors, and prior therapy Biologic Therapy Targets: TNF-: Infliximab (IV), adalimumab (SC), certolizumab pegol (SC) IL-12/23: Ustekinumab (IV induction, SC maintenance) Integrin: Vedolizumab (IV) IL-23: Risankizumab (IV induction, SC maintenance) JAK inhibition: Upadacitinib (oral) Surgical Management Surgery is indicated in approximately 7080% of patients with Crohns disease over their lifetime, per StatPearls
Conditions including acute hepatitis, cirrhosis, non-alcoholic fatty liver disease (NAFLD), and liver cancer have all been associated with elevated serum B12
This characteristic has made it an interesting molecule for exploratory studies in regenerative medicine, sports science, and biotechnology research
Waterproof & Floats: Ideal for flood scenarios or marine use
This peptide has been explored in some regenerative protocols for osteoarthritis, often in combination with HA or platelet-rich plasma (PRP)
